Alnylam Pharmaceuticals is to invest $250m to expand its facility in Massachusetts, US, to meet the growing demand for RNAi ...
Global VP Sustainability and Business Solutions and Head of Sustell™ at dsm-firmenich, reveals how digital sustainability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results